214 related articles for article (PubMed ID: 22071776)
1. Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases.
Bale R; Widmann G; Schullian P; Haidu M; Pall G; Klaus A; Weiss H; Biebl M; Margreiter R
Eur Radiol; 2012 Apr; 22(4):930-7. PubMed ID: 22071776
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic radiofrequency ablation (SRFA) for recurrent colorectal liver metastases after hepatic resection.
Schullian P; Johnston EW; Putzer D; Laimer G; Waroschitz G; Braunwarth E; Amann A; Maglione M; Bale R
Eur J Surg Oncol; 2021 Apr; 47(4):866-873. PubMed ID: 33032865
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of radiofrequency ablation and resection for resectable colorectal liver metastases.
Ko S; Jo H; Yun S; Park E; Kim S; Seo HI
World J Gastroenterol; 2014 Jan; 20(2):525-31. PubMed ID: 24574721
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysis.
Wang LJ; Zhang ZY; Yan XL; Yang W; Yan K; Xing BC
World J Surg Oncol; 2018 Oct; 16(1):207. PubMed ID: 30322402
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiofrequency ablation as first-line treatment of recurrent HCC following hepatic resection.
Schullian P; Laimer G; Putzer D; Levy E; Braunwarth E; Stättner S; Bale R
Eur J Surg Oncol; 2020 Aug; 46(8):1503-1509. PubMed ID: 32222261
[TBL] [Abstract][Full Text] [Related]
6. Microwave ablation with or without resection for colorectal liver metastases.
Stättner S; Jones RP; Yip VS; Buchanan K; Poston GJ; Malik HZ; Fenwick SW
Eur J Surg Oncol; 2013 Aug; 39(8):844-9. PubMed ID: 23769976
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update.
Mulier S; Ruers T; Jamart J; Michel L; Marchal G; Ni Y
Dig Surg; 2008; 25(6):445-60. PubMed ID: 19212117
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of stereotactic radiofrequency ablation for very large (≥8 cm) primary and metastatic liver tumors.
Schullian P; Johnston EW; Putzer D; Eberle G; Laimer G; Bale R
Sci Rep; 2020 Jan; 10(1):1618. PubMed ID: 32005871
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic Radiofrequency Ablation for Metastatic Melanoma to the Liver.
Bale R; Schullian P; Schmuth M; Widmann G; Jaschke W; Weinlich G
Cardiovasc Intervent Radiol; 2016 Aug; 39(8):1128-35. PubMed ID: 27055850
[TBL] [Abstract][Full Text] [Related]
10. Anatomical versus nonanatomical resection of colorectal liver metastases: is there a difference in surgical and oncological outcome?
Lalmahomed ZS; Ayez N; van der Pool AE; Verheij J; IJzermans JN; Verhoef C
World J Surg; 2011 Mar; 35(3):656-61. PubMed ID: 21161655
[TBL] [Abstract][Full Text] [Related]
11. The effect of radiofrequency ablation vs. liver resection on survival outcome of colorectal liver metastases (CRLM): a meta-analysis.
Bai H; Huangz X; Jing L; Zeng Q; Han L
Hepatogastroenterology; 2015; 62(138):373-7. PubMed ID: 25916066
[TBL] [Abstract][Full Text] [Related]
12. Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases.
Hof J; Wertenbroek MW; Peeters PM; Widder J; Sieders E; de Jong KP
Br J Surg; 2016 Jul; 103(8):1055-62. PubMed ID: 27193207
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes following microwave ablation for liver malignancies.
Leung U; Kuk D; D'Angelica MI; Kingham TP; Allen PJ; DeMatteo RP; Jarnagin WR; Fong Y
Br J Surg; 2015 Jan; 102(1):85-91. PubMed ID: 25296639
[TBL] [Abstract][Full Text] [Related]
14. Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases.
Hammill CW; Billingsley KG; Cassera MA; Wolf RF; Ujiki MB; Hansen PD
Ann Surg Oncol; 2011 Jul; 18(7):1947-54. PubMed ID: 21399885
[TBL] [Abstract][Full Text] [Related]
15. Surgical microwave ablation of otherwise non-resectable colorectal cancer liver metastases: Expanding opportunities for long term survival.
McEachron KR; Ankeny JS; Robbins A; Altman AM; Marmor S; D'Souza D; Schat R; Spilseth B; Jensen EH
Surg Oncol; 2021 Mar; 36():61-64. PubMed ID: 33316680
[TBL] [Abstract][Full Text] [Related]
16. Solitary colorectal liver metastasis: resection determines outcome.
Aloia TA; Vauthey JN; Loyer EM; Ribero D; Pawlik TM; Wei SH; Curley SA; Zorzi D; Abdalla EK
Arch Surg; 2006 May; 141(5):460-6; discussion 466-7. PubMed ID: 16702517
[TBL] [Abstract][Full Text] [Related]
17. Hepatectomy vs radiofrequency ablation for colorectal liver metastasis: a propensity score analysis.
Lee H; Heo JS; Cho YB; Yun SH; Kim HC; Lee WY; Choi SH; Choi DW
World J Gastroenterol; 2015 Mar; 21(11):3300-7. PubMed ID: 25805937
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic radiofrequency ablation (SRFA) of liver lesions: technique effectiveness, safety, and interoperator performance.
Widmann G; Schullian P; Haidu M; Bale R
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):570-80. PubMed ID: 21671150
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic Radiofrequency Ablation of Breast Cancer Liver Metastases: Short- and Long-Term Results with Predicting Factors for Survival.
Schullian P; Johnston E; Laimer G; Putzer D; Eberle G; Scharll Y; Ianetti-Hackl C; Bale R
Cardiovasc Intervent Radiol; 2021 Aug; 44(8):1184-1193. PubMed ID: 33825059
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of Ultrasound-Guided Radiofrequency Ablation of Recurrent Colorectal Cancer Liver Metastases after Hepatectomy.
Valls C; Ramos E; Leiva D; Ruiz S; Martinez L; Rafecas A
Scand J Surg; 2015 Sep; 104(3):169-75. PubMed ID: 25332220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
